Table 1 Literature review over miRNA quantitative RT–PCR studies in thyroid tumours
Material, Total sample | Tumour type/normal thyroid | Deregulated miRNA | Reference |
---|---|---|---|
Fresh-frozen tissue, n=10 | Matched pairs of 5 PTCs and 5 normal thyroids | miRNAs 221, 222 and 146b upregulated in PTC vs normal thyroid | |
Snap-frozen tissue, n=9 | 5 FTCs 4, FAs 4, normal thyroids | miRNAs 197 and 56 upregulated in FTC vs FA | |
Fresh frozen tissue, n=47 | 8 FAs and 39 PTCs | Precursor miRNAs 221, 222 and 181b-1 upregulated in PTC vs FA | |
Formalin-fixed paraffin-embedded tissue, n=20 | 10 PTCs (conventional variant) and 10 MNGs | miRNAs 21, 31, 221 and 222 upregulated in PTC vs MNG | |
Fresh-frozen and formalin-fixed paraffin-embedded tissue, n=20 | 20 ATCs | miRNAs 30d, 125b, 26 and 30-a-5p downregulated in ATC vs normal thyroid | |
Snap-frozen tissue, n=60 | 23 PTCs (18 conventional and 5 follicular variants) 9 FTCs, 8 FAs, 4 ACs, 4 PDCs, 2 MCs, 5 normal thyroids and 5 hyperplastic nodules | miRNAs 187, 221, 222, 181b, 146b, 155 and 224 upregulated in follicular cell-derived carcinomas with high variance between tumour type; miRNAs 187, 221, 222, 146b and 155 upregulated in PTC with strong relationship to mutational status | |
Formalin-fixed paraffin-embedded tissue, n=74 | 32 PTCs (27 conventional and 5 follicular variants) 24 FAs, 10 ‘borderline’ follicular lesions, 11 hyperplastic nodules, 2 FTCs and 5 normal thyroid | miRNA 146 upregulated in PTC vs non-papillary carcinomas; miRNAs 221 and 222 upregulated in PTC vs FA, hyperplastic nodules, normal thyroid but with substantial overlaps in individual cases; miRNA 146b indistinguishable between ‘borderline’ tumours and FA and lower than in PTC | |
Formalin-fixed paraffin-embedded tissue, n=113 | 50 PTCs (10 conventional, 10 tall cell and 30 follicular variants) 22 WDT-UMPs, 21 FTCs 10 FAs and 10 MNGs | Mean values of miRNAs 146b, 181b, 21, 221 and 222 upregulated in PTC; miRNA 146b upregulated in PTC-CT/PTC-TCV vs MNG/FA; substantial overlaps of all miRNAs in follicular cell-derived tumours; intermediate miRNA expression profile of PTC-FV | Our study |